Cargando…
Physiologically based pharmacokinetic model for the inhibition of acetylcholinesterase by organophosphate esters.
Organophosphate (OP) exposure can be lethal at high doses while lower doses may impair performance of critical tasks. The ability to predict such effects for realistic exposure scenarios would greatly improve OP risk assessment. To this end, a physiologically based model for diisopropylfluorophospha...
Autores principales: | Gearhart, J M, Jepson, G W, Clewell, H J, Andersen, M E, Conolly, R B |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
1994
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1566752/ https://www.ncbi.nlm.nih.gov/pubmed/7737042 |
Ejemplares similares
-
Development of a physiologically based pharmacokinetic model of trichloroethylene and its metabolites for use in risk assessment.
por: Clewell, H J, et al.
Publicado: (2000) -
Mechanisms of Organophosphate Toxicity and the Role of Acetylcholinesterase Inhibition
por: Aroniadou-Anderjaska, Vassiliki, et al.
Publicado: (2023) -
Physiologically based pharmacokinetic analyses of simple mixtures.
por: Krishnan, K, et al.
Publicado: (1994) -
Molecular Modeling Studies on the Multistep Reactivation Process of Organophosphate-Inhibited Acetylcholinesterase and Butyrylcholinesterase
por: Jończyk, Jakub, et al.
Publicado: (2021) -
Pharmacokinetics of toxic chemicals in breast milk: use of PBPK models to predict infant exposure.
por: Clewell, Rebecca A, et al.
Publicado: (2002)